Cart
sales@molnova.com
Dehydroabiethylamine
CAS No. 1446-61-3
Dehydroabiethylamine( Leelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955 )
Catalog No. M27157 CAS No. 1446-61-3
Dehydroabiethylamine is an inducer of hepatic CYP2B activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 31 | In Stock |
|
Biological Information
-
Product NameDehydroabiethylamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity.
-
DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsLeelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1446-61-3
-
Formula Weight285.475
-
Molecular FormulaC20H31N
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (350.30 mM)
-
SMILESCC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Okolotowicz KJ, et al. Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activationpathway. Bioorg Med Chem. 2010 Mar 1;18(5):1918-24.
molnova catalog
related products
-
CYP1B1-IN-5
CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.
-
Inz-1
Inz-1 is an effective and fungal-selective inhibitor of mitochondrial cytochrome bc1 with IC50s of 8.092 and 45.320 μM for yeast and human.
-
N-desmethyl Olanzapi...
N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.
